The seven enigmas of SARS-CoV-2: from the past to the future

Evangelos Andreakos1, Lisa Arkin2, Paul Bastard3,4,5,6

  • 1Laboratory of Immunobiology, Center for Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.

Journal of Human Immunity
|December 5, 2025
PubMed

Insights

The COVID Human Genetic Effort identified genetic and immune factors explaining severe COVID-19 and related conditions. This research advances understanding of infectious disease variability and pandemic preparedness.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Clinical variability in SARS-CoV-2 infection suggests underlying genetic and immune factors.
  • Inborn errors of immunity (IEI) can predispose individuals to severe infectious diseases.

Purpose of the Study:

  • To investigate the genetic and immunological basis of clinical variability in SARS-CoV-2 infection.
  • To identify monogenic IEI and phenocopies contributing to severe COVID-19 phenotypes.

Main Methods:

  • Patient-based research leveraging the COVID Human Genetic Effort.
  • International collaboration to analyze genetic and immunological data.

Main Results:

  • Deciphered pathogenesis of critical COVID-19 pneumonia (~15%) and multisystemic inflammatory syndrome in children (MIS-C, ~2%).
  • Genetically and immunologically defined neuro-COVID-19 in a child.
  • Delineated immunological mechanisms of COVID-toes.

Conclusions:

  • Patient-based research and international collaboration are powerful tools for discovering genetic drivers of infectious disease.
  • Findings have implications for developing medical strategies against future pandemics.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
470
Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.5K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.9K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K
Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.6K